Gregson R K, Warner J O, Radford M
Child Health, University of Southampton, U.K.
Respir Med. 1995 Aug;89(7):487-93. doi: 10.1016/0954-6111(95)90124-8.
This paper describes the results of a questionnaire survey on some aspects of nebulizer use, nebulizer instruction, and features relating to the recognition and management of deteriorating asthma. The study population consisted of 90 children with home nebulizers attending a paediatric asthma clinic, and 200 asthmatic children and 200 asthmatic adults whose nebulizers had been purchased directly from a manufacturer in the U.K. The results suggest that follow-up supervision of the patients who bought their own nebulizers occurred in only approximately 25% of cases. Written information focusing on the management of symptoms was also lacking. Peak flow meters were being under-used. Although the majority (77-100%) of patients were aware of the '4 h rule' for repeat use of bronchodilator therapy at home, there was still some confusion about the acceptable time interval and action to be taken should the dose be required more frequently. Very few (32%) in the nationwide adult group had a crisis action plan should the nebulizer fail to produce relief. This paper recommends that a simple treatment and crisis plan should be included with the purchased nebulizer, highlighting the key areas to be discussed by the patients with the doctor or other medical professionals. Such a package may prevent the occasional disaster that can occur with unsupervised nebulized bronchodilator usage.
本文描述了一项关于雾化器使用、雾化器指导以及与哮喘病情恶化的识别和管理相关特征的问卷调查结果。研究对象包括90名在家中使用雾化器的儿童,他们在一家儿科哮喘诊所就诊,以及200名哮喘儿童和200名哮喘成人,这些人的雾化器是直接从英国的一家制造商购买的。结果表明,购买了自己雾化器的患者中,只有约25%的病例得到了后续监督。同时也缺乏侧重于症状管理的书面信息。峰值流量计的使用不足。尽管大多数(77%-100%)患者知道在家中重复使用支气管扩张剂治疗的“4小时规则”,但对于可接受的时间间隔以及如果需要更频繁给药应采取的行动仍存在一些困惑。在全国范围内的成人组中,很少有人(32%)制定了雾化器无法缓解症状时的危机行动计划。本文建议,购买的雾化器应附带一份简单的治疗和危机计划,突出患者应与医生或其他医疗专业人员讨论的关键领域。这样的一套方案可能会防止在无人监督的情况下使用雾化支气管扩张剂时偶尔发生的灾难。